title: [The ovarian hyperstimulation syndrome. Institutional experience].
abstract: Thirty patients with OHS were analyzed; all of them had to be hospitalized. There was no difference as to sterility time and syndrome appearance. The use of menotropines caused more frequently the syndrome. There was multiple pregnancy in 33%. Abortion incidence was 16%. As the etiology is unknown there is not an adequate treatment, and care is for maintenance. Prevention is the best option.
authors.affiliation: Unidad de Reproducción Asistida, Instituto Nacional de Perinatología, SS, México, D.F.
authors.forename: C
authors.initials: C
authors.lastname: Serviere Zaragoza
authors.forename: A
authors.initials: A
authors.lastname: Camarero García
authors.forename: S
authors.initials: S
authors.lastname: Carranza Lira
authors.forename: A
authors.initials: A
authors.lastname: Kably Ambe
mesh_terms: D000328:Adult; D002996:Clomiphene / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use; D008800:Mexico; D016471:Ovarian Hyperstimulation Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D010062:Ovulation Induction; D011247:Pregnancy; D012189:Retrospective Studies
chemical_list: D002996:Clomiphene; D008596:Menotropins; D005640:Follicle Stimulating Hormone
vernacular_title: Síndrome de hiperestimulación ovárica. Experiencia institucional.